Kovitz Investment Group Partners LLC Reduces Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Kovitz Investment Group Partners LLC trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 42.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 111,849 shares of the real estate investment trust's stock after selling 81,350 shares during the period. Kovitz Investment Group Partners LLC's holdings in Healthpeak Properties were worth $1,489,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC increased its holdings in Healthpeak Properties by 42.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,750 shares of the real estate investment trust's stock worth $70,000 after purchasing an additional 1,712 shares in the last quarter. Envestnet Portfolio Solutions Inc. bought a new position in Healthpeak Properties in the 3rd quarter valued at about $124,000. Stratos Wealth Partners LTD. purchased a new position in shares of Healthpeak Properties during the fourth quarter valued at approximately $134,000. Koshinski Asset Management Inc. purchased a new position in Healthpeak Properties during the fourth quarter worth about $146,000. Finally, Sapient Capital LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter worth approximately $152,000. Institutional investors and hedge funds own 93.57% of the company's stock.

Analyst Ratings Changes

DOC has been the topic of several recent research reports. Wells Fargo & Company initiated coverage on shares of Healthpeak Properties in a report on Monday, March 25th. They set an "equal weight" rating and a $19.00 price objective on the stock. BNP Paribas upgraded Healthpeak Properties from a "neutral" rating to an "outperform" rating and increased their price objective for the stock from $19.00 to $21.00 in a report on Friday, April 26th. Wedbush upgraded shares of Healthpeak Properties from a "neutral" rating to an "outperform" rating in a report on Friday, May 3rd. Mizuho reissued a "buy" rating and set a $22.00 price objective on shares of Healthpeak Properties in a research note on Monday, April 22nd. Finally, Bank of America upgraded Healthpeak Properties from an "underperform" rating to a "buy" rating and increased their target price for the company from $18.00 to $25.00 in a research note on Monday, April 1st. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $18.50.

Healthpeak Properties Stock Performance

Shares of NYSE DOC traded up $0.10 during trading hours on Friday, reaching $19.55. The stock had a trading volume of 4,307,565 shares, compared to its average volume of 5,471,760. Healthpeak Properties, Inc. has a fifty-two week low of $15.24 and a fifty-two week high of $22.38. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.92. The firm has a market cap of $13.76 billion, a price-to-earnings ratio of 55.86, a PEG ratio of 1.91 and a beta of 1.01. The firm has a 50-day moving average of $18.23 and a 200-day moving average of $14.28.

Healthpeak Properties Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 17th. Shareholders of record on Monday, May 6th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.14%. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.23. The ex-dividend date is Friday, May 3rd. Healthpeak Properties's payout ratio is presently 342.87%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.